Chest cancer

The lung cancer research initiatives of the Respiratory Institute continue to offer significant new information about this widespread condition. In a study supported by an NIH RO1 grant, the Powell laboratory uses cutting-edge genomic techniques to pinpoint crucial biological pathways that separate aggressive from indolent early-stage lung cancers. After coverage for high-risk patients is allowed in 2015, the broad use of lung cancer CT screening will make this research increasingly important.

    Related Conference of Chest cancer

    April 27-28, 2026

    2nd World Congress on Pathology and Laboratory Medicine

    Paris, Aland Islands
    June 11-12, 2026

    5th World Summit on COPD

    Rome, Italy

    Chest cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in